These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes. Lopes-Virella MF; Carter RE; Baker NL; Lachin J; Virella G; Nephrol Dial Transplant; 2012 Apr; 27(4):1416-23. PubMed ID: 21856760 [TBL] [Abstract][Full Text] [Related]
6. Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy. Kahri J; Groop PH; Elliott T; Viberti G; Taskinen MR Diabetes Care; 1994 May; 17(5):412-9. PubMed ID: 8062608 [TBL] [Abstract][Full Text] [Related]
7. LDL subclasses in IDDM patients: relation to diabetic nephropathy. Lahdenperä S; Groop PH; Tilly-Kiesi M; Kuusi T; Elliott TG; Viberti GC; Taskinen MR Diabetologia; 1994 Jul; 37(7):681-8. PubMed ID: 7958539 [TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Festa A; Kopp HP; Schernthaner G; Menzel EJ Diabetologia; 1998 Mar; 41(3):350-6. PubMed ID: 9541177 [TBL] [Abstract][Full Text] [Related]
9. The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM. Levitt NS; Adams G; Salmon J; Marks IN; Musson G; Swanepoel C; Levy M; Byrne MJ Diabetes Care; 1995 Jul; 18(7):971-4. PubMed ID: 7555558 [TBL] [Abstract][Full Text] [Related]
10. Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre-oxidative condition? Moro E; Alessandrini P; Zambon C; Pianetti S; Pais M; Cazzolato G; Bon GB Diabet Med; 1999 Aug; 16(8):663-9. PubMed ID: 10477211 [TBL] [Abstract][Full Text] [Related]
11. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy. Yokoyama H; Jensen JS; Jensen T; Deckert T J Intern Med; 1995 May; 237(5):519-23. PubMed ID: 7738493 [TBL] [Abstract][Full Text] [Related]
12. Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls. Mironova M; Virella G; Virella-Lowell I; Lopes-Virella MF Clin Immunol Immunopathol; 1997 Oct; 85(1):73-82. PubMed ID: 9325072 [TBL] [Abstract][Full Text] [Related]
16. Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study. Yip JW; Jones SL; Wiseman MJ; Hill C; Viberti G Diabetes; 1996 Dec; 45(12):1729-33. PubMed ID: 8922358 [TBL] [Abstract][Full Text] [Related]
17. Soluble LDL-immune complexes in type 2 diabetes and vascular disease. Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029 [TBL] [Abstract][Full Text] [Related]
18. Association between plasma oxidized low-density lipoprotein and diabetic nephropathy. Ujihara N; Sakka Y; Takeda M; Hirayama M; Ishii A; Tomonaga O; Babazono T; Takahashi C; Yamashita K; Iwamoto Y Diabetes Res Clin Pract; 2002 Nov; 58(2):109-14. PubMed ID: 12213352 [TBL] [Abstract][Full Text] [Related]
19. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM. Crepaldi G; Carta Q; Deferrari G; Mangili R; Navalesi R; Santeusanio F; Spalluto A; Vanasia A; Villa GM; Nosadini R Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979 [TBL] [Abstract][Full Text] [Related]
20. High levels of AGE-LDL, and of IgG antibodies reacting with MDA-lysine epitopes expressed by oxLDL and MDA-LDL in circulating immune complexes predict macroalbuminuria in patients with type 2 diabetes. Lopes-Virella MF; Hunt KJ; Baker NL; Virella G; J Diabetes Complications; 2016; 30(4):693-9. PubMed ID: 26861948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]